Comparison of short- and mid-term outcomes of Italian- and German-speaking patients after an interdisciplinary pain management programme in Switzerland: A prospective cohort study. by Benz, Thomas et al.
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
ORIGINAL REPORT
J Rehabil Med 2019; 51: 127–135
doi: 10.2340/16501977-2514Journal Compilation © 2019 Foundation of Rehabilitation Information. ISSN 1650-1977
This is an open access article under the CC BY-NC license. www.medicaljournals.se/jrm
COMPARISON OF SHORT- AND MID-TERM OUTCOMES OF ITALIAN- AND 
GERMAN-SPEAKING PATIENTS AFTER AN INTERDISCIPLINARY PAIN 
MANAGEMENT PROGRAMME IN SWITZERLAND: A PROSPECTIVE COHORT 
STUDY
Thomas BENZ, MSc1,2*, Susanne LEHMANN, RN1, Roberto BRIOSCHI, MSc1, Achim ELFERING, PhD2, André 
AESCHLIMANN, MD1 and Felix ANGST, MD, MPH1
From the 1Research Department, Rehabilitation Clinic “RehaClinic”, Bad Zurzach, and 2Institute of Psychology, University of Bern, 
Bern, Switzerland
LAY ABSTRACT
This study examined the health of patients with 
chronic pain who participated in a specific rehabilita-
tion programme for chronic pain. Patients’ health was 
measured before participating in the programme, at 
the end of the programme, and after the programme. 
German-speaking patients were compared with Italian-
speaking patients. Both groups participated in the same 
pain management programme with the same therapies, 
held either in German or in Italian. Italian-speaking and 
German-speaking patients improved immediately after 
the programme, but Italian-speaking patient reported 
lower improvements. The measurements after the pro-
gramme showed that German-speaking patients could 
maintain the improvements, whereas the Italian-speak-
ing patients lost the positive effects of the programme 
over time. In conclusion, Italian-speaking patients may 
have special needs in pain management and the level of 
acculturation may influence the results.
Objective: To quantify and compare the course of 
health-related quality of life of immigrant native Ita-
lian-speaking and German-speaking patients before 
and after an interdisciplinary pain programme.
Design: Prospective cohort study with 1–12 month 
follow-up.
Subjects: Fibromyalgia, generalized widespread 
pain, and chronic non-specific back pain patients 
(Italian-speaking n = 96, German-speaking n = 199).
Methods: Score changes measured with the Short 
Form 36 (SF-36) were compared with multivariate 
analysis using standardized mean differences (SMD), 
adjusted for sex, education and the baseline score.
Results: At baseline, health of the Italian-speaking 
patients was worse than for the German-speaking 
patients. Adjusted SMDs showed significantly bet-
ter improvements in the German group compared 
with the Italian group: SF-36 Physical functioning 
SMD = 0.54 (at discharge) and 0.49 (at 12 months), 
General health SMD = 0.71 and 0.44, Vitality 
SMD = 0.43 and 0.48 in one sample. In the other sam-
ple, the corresponding SMDs were 0.06 (discharge), 
0.50 (3 months) and 0.47 (6 months) for Bodily pain. 
Conclusion: State of health was better and health 
improvements were greater in German-speaking pa-
tients compared with Italian-speaking patients. Pa-
tients with a migration background may have special 
needs in therapeutic management, and addressing 
these might enhance the positive outcome in the 
short- and mid-term.
Key words: rehabilitation; interdisciplinary pain management 
programme; fibromyalgia; back pain; language; socio-cultural 
factors.
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Chronic pain occurs in countries with different ethnic, racial, and cultural backgrounds, and has 
an adult prevalence of 19% in Europe (1). “Ethnic and 
racial differences” have been described for response to 
experimental pain, as well as for the perception, expe-
rience and treatment of pain (2, 3). Reasons proposed 
for ethnic differences in the prevalence of widespread 
pain include psychosocial or cultural differences, ge-
netic predisposition, and the influence of physical or 
social environment (4, 5). 
Interdisciplinary biopsychosocial rehabilitation 
for chronic low back and fibromyalgia reduces pain 
intensity, symptom impact, disability and improves 
functional capacity and work status (6–9). Based on 
a biopsychosocial treatment approach for chronic 
pain, interdisciplinary pain management programmes 
(IPMP) consider that pain, disability, and participation 
are not only the consequence of a biomedical cause 
(10, 11). Biological, psychological and social factors 
influence the development, course and maintenance 
of chronic pain (12, 13). These dimensions, as well as 
their interactions, are therefore, recommended to be 
an integral part of the treatment of low back pain and 
fibromyalgia (14, 15).
Social factors can be defined as “external facts 
and circumstances that influence and control an 
individual’s behaviour or attitudes related to pain”, 
e.g. language (16). Language difficulties may lead to 
misunderstandings relating to treatment intentions and 
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128 T. Benz et al.
decisions, advice given after therapy, the healthcare 
and insurance system, as well as educational treatment, 
and may not be sufficiently taken into account by the 
therapists. Social factors were shown to influence 
functional limitation and disability in low back pain, 
with social disadvantage being one of the important 
factors (16).
In Switzerland, the population with foreign citi-
zenship has grown continuously since 1983 and had 
reached 24.6% of the total population by 2015. This is 
one of the highest percentages of foreign residents in 
Europe. In Switzerland, 84.7% of the foreign perma-
nent resident population are of European origin, and 
the largest group of foreigners are Italian at 15.2% 
(17). Reactions to health-illness process are different 
in each culture and are influenced by the patient and 
by interpretations and attitudes that lead to a certain 
way of living with the disorder (18). More intercul-
tural competence, awareness and culturally sensitive 
attitudes are required in medical treatment in order to 
meet the needs of these different groups better, e.g. by 
standardized IPMPs held in specific languages.
No studies have investigated the differences in chan-
ges as a result of the same IPMP with the same therapy 
components held in 2 different languages, administered 
by the same therapists. The objective of this study 
was to describe and to examine state (at baseline) and 
short-term (at discharge) as well as mid-term (at 3-, 6-, 
and 12-month follow-up) changes in biopsychosocial 
health and quality of life in Italian-speaking patients 
(ISP) with fibromyalgia, generalized widespread pain 
and chronic non-specific back pain before and after 
a standardized 4-week IPMP in the Italian language. 
Furthermore, the study aimed to compare the results of 
the ISP with the results of German-speaking patients 
(GSP) at follow-ups. 
METHODS
Patients
Patients included in this study were recruited at the pain cen-
tre of the rehabilitation clinic “RehaClinic” in Bad Zurzach, 
Switzerland. All patients with chronic non-specific back pain, 
fibromyalgia according to the American College of Rheuma-
tology (ACR) definition (19), or generalized widespread pain 
(pain in all 4 body quadrants not fulfilling the ACR criteria of 
1990 (19)) who attended the “Zurzach Interdisciplinary Pain 
Program” (ZISP) were invited to participate. Further inclusion 
criteria were age ≥ 18 years and chronic pain for ≥ 3 months. Ex-
clusion criteria were severe somatic or mental illness/condition 
that prevented participation in the IPMP, insufficient language 
skills (reading and writing) to complete the assessment tool, 
and refusal to participate in the study or the IPMP.
Prior to inclusion in the IPMP and based on the admission 
report, potential participants were contacted by telephone by 
the programme leader (RB) or his assistant (both of whom are 
bilingual in German and Italian) to complete inclusion and ex-
clusion criteria and to assess oral language skills (listening and 
speaking). Allocation to the groups was based on oral language 
skills and not on migration background. For example, all patients 
participating in the German-speaking programme had excellent 
oral German language skills, which were an inclusion criteria. 
Patients with insufficient oral German or Italian language skills 
(exclusion criteria) were admitted to a different, individual 
IPMP in our clinic. 
Each group underwent a specific Italian- or German-speaking 
IPMP. This means that all information and instructions were 
given either in German or Italian. Both language-specific pro-
grammes consisted of the same therapy components, the same 
therapeutic content, and the same number of therapies. All 
therapies in the programme were provided by the same therapists 
for the German, as well as for the Italian, group. 
Written informed consent was obtained from all participants. 
The study protocol was approved by the Local Ethics Com-
mission (Health Department in Aarau, Switzerland, EK AG 
2008/026).
Intervention
The ZISP is a 4-week, standardized, comprehensive, inpatient 
IPMP in groups. The IPMP focused on chronic musculoskeletal 
pain disorders and consisted of active physiotherapy, and ae-
robic endurance training, Qigong/tai chi exercises, individual 
psychotherapy including cognitive behavioural therapy, par-
ticipation in a pain coping group, relaxation therapy, humour 
therapy, horticultural therapy (since April 2006), information 
and education about the pathophysiology of pain mechanisms 
and management of chronic disabling pain, nursing care, and 
regular medical consultations, including drug therapy. Details 
of the IPMP are provided elsewhere (6, 7). 
Data sampling
In this prospective cohort study, 2 different samples are descri-
bed and analysed. Sample 1 was collected between 2001 and 
2005 with follow-up measurements at 3 and 6 months (Fig. 1), 
sample 2 between 2006 and 2014 with follow-up measurements 
at 12 months. In 2006, the follow-up measurements at 3 and 6 
months were replaced by one follow-up measurement at 1 year 
after entry to the programme. This decision was based on the 
findings for the GSP analysed in sample 1. In this study, only 
mid-term results were calculated (3 and 6 month follow-up) 
(6). In the following, long-term results came into our focus of 
interest, especially because these could not otherwise be found 
in the literature at that time. A further reason for the restart with 
the “revised” sample strategy (sample 2) of the IPMP was that 
a new, improved version (version 2) of the Medical Outcomes 
Study Short Form 36 Health Survey (SF-36) was available and 
included in the measurements (20).
For these reasons, the size of sample 1 was limited. The ana-
lysis based on sample 1 revealed relatively high effect sizes for 
many health scales (6). Thus, data sampling for sample 2 was 
considered sufficient after having reached n ≥ 60 for both the 
German- and the Italian-speaking group. Doubling the sample 
size up to n = 120 for each group would narrow the width of 
the 95% confidence interval of the effect sizes by 0.02. This 
gain was considered to be too small in face of the burden of 
doubling the sampling effort.
The difference in number of included patients in sample 1 and 
the difference in duration of inclusion of the patients in sample 
2 were due to the naturalistic study design and the maximal 
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129Comparison of Italian- and German-speaking patients with chronic pain 
capacity of 6 patients per treatment group in the ZISP. Only 
one group of patients was treated at a time. Twice a year, the 
programme was held in Italian for the ISP. This means that 2 
groups with ISP and 10 groups with GSP were treated per year. 
This resulted in an unbalanced number of patients included in 
sample 1 with the same observation duration (Fig. 1). In order 
to obtain almost equal numbers of patients, different observation 
periods were chosen in sample 2.
Measures
Sociodemographic and potentially confounding parameters, 
such as age, sex, occupation, living conditions, sports, and 
formal education, were recorded at admission to the clinic on 
a standardized form used previously in many studies (6). Co-
morbidities were retrieved from the medical history.
The SF-36 comprehensively measures the dimensions of 
quality of life, physical, mental and psychosocial health (21). 
This instrument contains 36 items in 8 health domains: bodily 
pain, physical functioning, role physical, general health, vita-
lity, social functioning, role emotional, and mental health. It 
is a commonly used measurement for the self-assessment of 
health-related quality of life in chronic pain diseases, such as 
fibromyalgia (22). It has already been used to assess the efficacy 
of interventions in rheumatology, physiotherapy, drug treatment, 
tai chi and many others (22). The validated German version was 
used for the GSP (23). In sample 1, version 1 (21) was used and 
in sample 2, version 2 (20). For the ISP, the validated Italian 
version was used (24).
Analysis
Patients from sample 1 were assessed at baseline (T=0), 
discharge (T1; short-term), i.e. 4 weeks after entry, 3 months 
after entry (T2; mid-term), and 6 months after entry (T3; mid-
term). Patients from sample 2 were assessed at baseline (T=0), 
discharge (T1; short-term), i.e. 4 weeks after entry, and 12 
months after entry (T4; mid-term). 
SF-36 scores were transformed into scales ranging from 0 
(“maximal symptoms or limitation”) to 100 (“no symptoms or 
limitation”) to ease comparison of the descriptive data (25). The 
specific “missing rules” of the instrument had to be fulfilled for 
determination of the scales. This means that at least 50% of the 
items had to be completed for each of the SF-36 scales (25).
Sociodemographic and disease-relevant frequency data 
were compared by the χ2 test and continuous data by the non-
parametric Wilcoxon test. Changes on the SF-36 scales between 
baseline and follow-up were quantified by multivariate stan-
dardized mean differences (SMD) (26). For each SF-36 score, 
stepwise multivariate linear regression was used to model the 
individual score changes (baseline to follow-up) as dependent 
variables. The same independent variables were used for all 
scales in both samples: group allocation (1=GSP, 0=ISP), ba-
seline score, and sex and education (27). The last 3 variables 
are well-known as potential confounders for the score changes 
between baseline and follow-up. The number of confounders is 
limited by the number of patients in the smallest group/10 (28). 
The coefficient/slope of the group allocation variable was then 
equal to the adjusted score difference and was used to calculate 
the multivariate SMDs (26).
The SMD equals the difference of the mean score changes 
(baseline to follow-up) between the 2 groups (GSP and ISP) 
divided by the pooled standard deviation of the score changes 
(baseline to follow-up) of the 2 compared groups (26). The 
pooled variance equals the mean of the 2 score change varian-
ces, which is weighted by the number of patients. Intervals for 
95% confidence (95% CI) for the SMD and t-test based type I 
errors (p) for testing SMD > 0.00 (zero outside of the 95% CI) 
Fig. 1. Flow chart of study participants.
German-speaking patients 
 Inclusion from January 2001 
– November 2005 
n=255 
Exclusion n=39 
• Written language skills n=31 
• Other reasons n=8 
Complete data included in 
analysis 
n=136 
Italian-speaking patients 
 Inclusion from January 2001 
– November 2005 
n=53 
Exclusion n=9 
• Written language skills 
n=1(Portuguese) 
• Other reasons n=8 
Complete data included in 
analysis 
n=35 
German-speaking patients 
Inclusion from January 2006 
– April 2009 
n=165 
 
Exclusion n=35 
• Written language skills n=32 
• Other reasons n=3 
Complete data included in 
analysis 
n=63 
Italian-speaking patients 
 Inclusion from January 2006 
– November 2014 
n=119 
 
Baseline to 1 (T1) and 12 month (T4) follow-up 
 
Exclusion n=19 
• Written language skills 
n=7(Portuguese) 
• Compliance n=3 
• Other reasons n=9 
Complete data included in 
analysis 
n=61 
Baseline to 1 (T1), 3 (T2) and 6 month (T3) follow-up 
Sample 2 Sample 1 
Drop out n=80 
• Premature discharge n=3 
• Compliance n=77 
Drop out n=67 
• Premature discharge n=9 
• Compliance n=57 
Drop out n=9 
 Premature discharge n=1 
 Compliance n=8
Drop out n=39 
•  Premature discharge n=4 
•  Compliance n=35
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130 T. Benz et al.
were calculated (see Tables II and III). An SMD of 0.20–0.49 
is considered small, 0.50–0.79 moderate, and ≥ 0.80 large (29).
All analyses were performed using the statistical software 
package IBM SPSS 23.0 for Windows® (SPSS Inc., Chicago, 
IL, USA). 
RESULTS
Patients
The flow chart of participants is shown in Fig. 1. 
Complete data were available for analysis of 136 GSP 
and 35 ISP in sample 1, and 63 GSP and 61 ISP in 
sample 2. Reasons for exclusion with exact numbers 
are shown in Fig. 1.
Sociodemographic variables and disease-relevant 
characteristics are given in Table I. All participants were 
Caucasian. The mean participant’s age was comparable 
in both samples. Comparing sample 1 with sample 2, an 
important difference was found in sex, with no signifi-
cant difference in sample 1, but in sample 2 more males 
participated in the study (p < 0.001). In education, ISP 
were significantly less educated than GSP, especially in 
sample 2. In sample 1, higher education was reported 
in GSP (73%) vs ISP (9%) in sample 1 and in sample 
2 (62% vs 15%). Significant occupational differences 
were found in sample 1 (p < 0.001), with 80% of the 
ISP being unemployed. In sports, ISP were less active 
(p = 0.034). In both samples, most ISP were living with a 
partner. In sample 1, 66% of ISP had 3 or more comorbi-
dities in contrast to 43% of the GSP. In both samples, this 
characteristic was comparable. In summary, ISP were 
less educated, less occupied, more often married and 
less active in sports than the GSP, especially in sample 1.
Sensitivity analysis
Age, sex and SF-36 scores for completers were 
compared with the baseline scores of drop-outs for 
ISP and GSP in sample 1 and sample 2 each (i.e. 4 
comparisons). No significant differences were found 
in all 4 comparisons in age and sex. In sample 1, sig-
nificant differences were found in the GSP in Physical 
functioning (p = 0.034) and in the ISP in Role Physical 
(p = 0.032) and in Role emotional (p = 0.016). In sample 
2, the only significant difference was in the GSP in 
Role emotional (p = 0.011). All other scores differences 
within the 4 groups were not significant.
Table I. Sociodemographic and disease-related characteristics at baseline
Sample 1 Sample 2
German-speaking 
patients (n = 136)
Italian-speaking 
patients (n = 35) p-value
German-speaking patients
(n = 63)
Italian-speaking 
patients (n = 61) p-value
Age, years, mean (SD) 46.5 (12.1) 48.9 (7.7) 0.132 48.6 (10.0) 49.9 (9.0) 0.260
Female, % 80.1 74.3 0.448 85.7 45.9 < 0.001
Education, %
No school 0.0 20.0 < 0.001 3.2 7.3 < 0.001
Basic school (8–9 years) 27.2 71.4 34.9 78.2
Vocational training 55.1 5.7 46.0 10.9
College/high school 11.0 2.9 12.7 1.8
Technical college 2.9 0.0 1.6 0.0
University 3.7 0.0 1.6 1.8
Occupation, %
Not working 36.0 80.0 < 0.001 66.1 67.9 0.949
Part-time work (7–41 h/week) 43.4 14.3 27.5 23.1
Full-time work (≥ 42 h/week) 16.9 2.9 6.4 9.0
Living conditions, %
Alone 22.1 2.9 0.027 27.0 12.5 0.022
With partner 71.3 91.4 54.0 80.4
With other persons 6.6 5.7 19.0 7.1
Sport, %
No sports 48.5 77.4 0.034 50.8 60.0 0.324
<1 h/week 16.9 6.5 23.8 10.9
1–2 h/week 23.5 12.9 12.7 16.4
>2 h/ week 11.0 3.2 12.7 12.7
Diagnosis, %
Fibromyalgia/Generalized 
widespread pain
59.6 48.6 0.241 42.9 44.3 0.875
Chronic non-specific back pain 40.4 51.4 57.1 55.7
Comorbidities, %
None 9.6 2.9 0.179 7.9 4.9 0.300
1 20.6 11.4 15.9 23.0
2 27.2 20.0 14.3 31.1
3 23.5 31.4 23.8 14.8
4 8.1 20.0 19.0 8.2
5 5.1 11.4 9.5 1.6
≥ 6 5.9 2.9 9.5 1.6
h/week: hours per week; p-value: p-values with significance level set at ≤ 0.05.
www.medicaljournals.se/jrm
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
131Comparison of Italian- and German-speaking patients with chronic pain 
Outcome and comparison of score changes (baseline 
to follow-up)
At baseline, physical and psychosocial health for the 
ISP were worse than for the GSP in both samples, 
with the exception of less vitality and mental health 
in sample 1 (Table II) and less pain in sample 2 (Table 
III). However, the differences in the baseline scores 
were not statistically tested for significance because 
the baseline scores were included in the multivariate 
analysis as confounders. 
Immediately after the programme at discharge (T1), 
GSP improved on all scales in both samples. ISP im-
proved on 7/8 scales in sample 1 and 6/8 in sample 
2. However, the 3 negative score changes were very 
small (≥ –0.51 score points). In sample 1, the GSP 
improved most on Vitality (mean m=14.73), whereas 
the ISP improved most on Social functioning (12.54). 
In the following course (T2, T3, T4), the improve-
ments decreased slightly for the GSP but more mar-
kedly for the ISP with increasing time. For example, 
in Bodily pain, the score changes were 8.75 (T1)/8.92 
(T2)/7.49 (T3) for the GSP, but 10.20/3.33/–1.00 for 
the ISP in sample 1. In sample 2, the corresponding 
score changes were 8.27 (T1)/8.22 (T4) for GSP and 
7.51/2.25 for ISP. At the 6-month follow-up (T3), 8/8 
score changes showed improvement in the GSP, while 
5/8 showed worsening, and 2/8 showed no change in 
the ISP. At the 12-month follow-up (T4), 8/8 score 
changes showed improvement in the GSP, while 7/8 
showed worsening in the ISP. 
Table II. Sample 1: SF-36 scores at baseline (T0), at discharge from the pain management programme (T1), at 3-month follow-up 
(T2) and 6-month follow-up (T3) of German- (n = 136) and Italian-speaking patients (n = 35)
Mean (SD)
Baseline (T0)
Mean (SD)
Difference discharge to baseline
(T1–T0)
Difference between 3-month follow-
up and baseline (T2–T0)
Difference between 6-month 
follow-up and baseline (T3–T0)
Mean (SD) SMD [95% CI] p-value Mean (SD) SMD [95% CI] p-value Mean (SD) SMD 95% CI] p-value
SF-36 Physical 
functioning
G 41.48 (21.09) 9.68 (18.65) 0.321 
[–0.050,0.692]
0.084 7.38 (21.65) 0.237 
[–0.142,0.617]
0.216 8.13 (21.36) 0.436 
[0.064,0.809]
0.018
I 35.29 (17.49) 4.71 (15.86) 3.48 (17.65) 0.00 (19.29)
SF-36 Role 
physical
G 8.46 (19.30) 11.82 (30.45) 0.572 
[0.197,0.947]
0.002 12.13 (33.61) 0.413 
[0.032,0.794]
0.029 8.27 (32.35) 0.404 
[0.031,0.776]
0.029
I 2.14 (9.34) 2.14 (17.54) 1.52 (15.23) 0.00 (12.13)
SF-36 Bodily 
pain
G 19.55 (13.98) 8.75 (16.08) 0.055 
[–0.314,0.425]
0.769 8.92 (18.09) 0.502 
[0.120,0.884]
0.007 7.49 (20.73) 0.465 
[0.092,0.839]
0.011
I 17.97 (10.48) 10.20 (13.51) 3.33 (12.49) –1.00 (14.87)
SF-36 General 
health
G 41.61 (16.83) 3.00 (14.08) 0.524 
[0.150,0.898]
0.004 1.36 (15.83) 0.356 
[–0.029,0.742]
0.064 2.86 (17.34) 0.481 
[0.108,0.855]
0.009
I 31.00 (10.76) –0.14 (12.80) –2.97 (12.75) –3.57 (13.91)
SF-36 Vitality G 24.81 (16.07) 14.73 (16.84) 0.598 
[0.222,0.973]
0.001 9.04 (16.12) 0.577 
[0.189,0.965]
0.002 7.44 (17.98) 0.612 
[0.237,0.988]
0.001
I 30.94 (15.32) 3.06 (17.47) –2.59 (18.87) –5.80 (18.09)
SF-36 Social 
functioning
G 43.09 (25.41) 11.85 (27.47) 0.408 
[0.035,0.780]
0.027 8.97 (25.46) 0.450 
[0.069,0.832]
0.017 5.67 (28.47) 0.371 
[–0.001,0.743]
0.045
I 31.66 (18.53) 12.54 (18.11) 4.88 (19.55) –1.46 (16.80)
SF-36 Role 
emotional
G 31.09 (40.99) 13.12 (41.36) 0.423 
[0.051,0.796] 
0.022 12.99 (42.78) 0.197 
[–0.183,0.576]
0.306 8.12 (46.54) 0.175 
[–0.195,0.546]
0.350
I 12.37 (30.35) 9.51 (29.82) 15.12 (31.27) 10.46 (37.76)
SF-36 Mental 
health
G 46.24 (19.83) 9.85 (15.95) 0.323 
[–0.048,0.694]
0.082 5.97 (16.49) 0.623 
[0.234,1.012]
0.001 3.43 (17.59) 0.465 
[0.092,0.838]
0.011
I 47.46 (18.81) 5.51 (14.63) –3.03 (18.72) –5.29 (19.19)
Mean: arithmetic mean; SD: standard deviation; SMD: standardized mean difference; 95% CI: 95% confidence interval; p-value: statistical significance comparing 
German- with Italian-speaking patients; SF-36: Medical Outcomes Study Short Form 36 Health Survey; G: German-speaking patients, I: Italian-speaking patients.
Table III. Sample 2: SF-36 scores at baseline (T0), at discharge from the pain management programme (T1), and at the 12 month 
follow-up (T4) of German- (n = 63) and Italian-speaking patients (n = 62)
Mean (SD)
Baseline (T0) Difference from discharge to baseline (T1–T0)
Difference of 1 year follow-up to baseline 
(T4–T0)
Mean (SD) Mean (SD) SMD 95% [CI] p-value Mean (SD) SMD [95% CI] p-value
SF-36 Physical functioning G 43.33 (19.18) 6.43 (17.45) 0.543 [0.186,0.899] 0.002 4.76 (17.52) 0.491 [0.131,0.851] 0.005
I 37.46 (18.97) 1.30 (15.58) –0.69 (19.41)
SF-36 Role physical G 26.95 (15.31) 9.67 (20.13) 0.531 [0.175,0.887] 0.002 5.86 (19.28) 0.558 [0.196,0.919] 0.001
I 17.70 (18.17) 3.77 (26.06) –1.31 (20.99)
SF-36 Bodily pain G 16.81 (12.99) 8.27 (15.59) –0.030 [–0.379,0.320] 0.868 8.22 (20.90) 0.263 [–0.093,0.619] 0.141
I 18.33 (12.46) 7.51 (9.45) 2.25 (14.67)
SF-36 General health G 39.38 (17.66) 3.84 (18.43) 0.712 [0.351,1.073] 0.000 0.38 (18.89) 0.441 [0.082,0.800] 0.012
I 30.25 (14.13) –0.08 (15.67) –2.97 (15.24)
SF-36 Vitality G 26.78 (14.70) 10.75 (17.98) 0.429 [0.076,0.783] 0.014 4.73 (19.13) 0.479 [0.120,0.839] 0.007
I 24.36 (17.12) 5.82 (17.19) –0.19 (20.27)
SF-36 Social functioning G 40.29 (26.33) 10.06 (22.91) 0.239 [–0.112,0.590] 0.177 3.59 (32.56) 0.231 [–0.125,0.586] 0.198
I 37.49 (24.86) 5.31 (23.98) –3.48 (25.00)
SF-36 Role emotional G 45.10 (30.90) 4.25 (27.43) 0.473 [0.118,0.827] 0.007 2.78 (32.70) 0.473 [0.114,0.833] 0.007
I 29.89 (30.55) –0.51 (31.33) –6.16 (39.26)
SF-36 Mental health G 46.35 (22.17) 6.83 (14.65) 0.230 [–0.121,0.581] 0.193 4.44 (20.93) 0.575 [0.213,0.937] 0.001
I 39.26 (20.39) 4.18 (19.58) –3.62 (23.15)
Mean: arithmetic mean; SD: standard deviation; SMD: standardized mean difference; CI: 95% confidence interval; p-value: statistical significance comparing 
German- with Italian-speaking patients; SF-36: Medical Outcomes Study Short Form 36 Health Survey; G: German-speaking patients; I: Italian-speaking patients.
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This led to increasing levels of SMDs during the 
course, since they quantify the differences of the score 
changes between GSP and ISP. However, adjustment 
for the confounders attenuated those differences during 
the course. For example, on Bodily pain, the observed 
score changes (listed above) led to bivariate, unad-
justed SMDs of –0.093 (T1)/0.324 (T2)/0.429 (T3), 
but 0.055/0.502/0.465 multivariate, adjusted SMDs 
in sample 1. The differences on Bodily pain in sample 
2 were not statistically significant; the adjusted SMD 
at baseline was –0.030 (p = 0.868) and increased to 
a SMD of 0.263 (p = 0.141). The same was true for 
Social functioning. 
Significant change differences between GSP and 
ISP in sample 1 at each follow-up measurement were 
seen on the following scales: Role physical (adjusted 
SMD=0.572, 0.413, 0.404 for T1 to T3), Vitality 
(0.598, 0.577, 0.612), and Social functioning (0.408, 
0.450, 0.371). In sample 2, Physical functioning 
(adjusted SMD = 0.543, 0.491 for T1 and T4), Role 
physical (0.531, 0.558), General Health (0.712, 0.441), 
Vitality (0.429, 0.479), and Role emotional (0.473, 
0.473) showed significant differences. 
In total, 5 of 8 SMDs were statistically significant 
(p ≤ 0.027) in both samples at discharge and at the 
3-month follow-up. At the 6-month follow-up in sam-
ple 1, 7 SMDs (p ≤ 0.045) and at 1-year follow-up, 6 
SMDs (p ≤ 0.012) were statistically significant.
Of the total of 8 health dimensions, 5 showed 
significant differences at discharge, 5 at the 3-month 
follow-up, and 7 at the 6-month follow-up in sample 
1. In sample 2, the corresponding numbers were 5 
(discharge) and 6 (12-month follow-up). 
DISCUSSION
This study compared short- and mid-term changes in 
the biopsychosocial health and quality of life of ISP 
with GSP with chronic pain before and after a stan-
dardized IPMP. GSP improved in all measured scales 
at discharge and the effects remained almost stable in 
the follow-up measurements. In contrast, ISP showed 
less improvement on most scales at discharge and lost 
these positive effects completely over time.
These score change differences resulted in statisti-
cally significant adjusted SMDs on Role physical and 
Vitality, as well as, although somewhat less on General 
health over the course. At the mid-term follow-ups 
(6 and 12 months), all but one of the scales showed 
significant differences in favour of the GSP. These 
prominent differences cannot be explained by dif-
ferences in therapy because both groups underwent 
the same structured standardized IPMP held in the 
specific language.
The main focus of the study was to explore possible 
differences between GSP and ISP. The naturalistic de-
sign of the study is one of the factors that led to baseline 
differences. The design of the study did not allow us 
to draw causal conclusions that explain the differences 
in the score changes of the 2 groups, the SMDs. Some 
cofactors may be found in the sociodemographic and 
disease-related characteristics (Table I), and some 
in parameters that were not assessed (e.g. sickness 
benefits from the insurance). Some can be found in 
existing literature: ethnicity including cultural, beha-
vioural and attitudinal norms and systems of meaning 
(5, 30, 31) and socioeconomic level (4, 5) including 
educational level and work status. For the 3 most re-
levant confounders, sex, education and baseline score, 
analysis of the differences was adjusted by multivariate 
regression analysis. All 3 cofactors are well-known to 
affect and confound the outcome by epidemiological 
reasons and showed the biggest differences between 
the 2 groups at baseline. Even after correction of the 
unequal distributions of those 3 cofactors, substantial 
and statistically significant differences in outcome were 
observed between the 2 groups.
Although language has been described as “a proxy 
for acculturation” and as “a significant marker of 
cultural identity”, empirical data to support this are 
lacking (32). An improving knowledge of the German 
language in combination with an increasing length 
of stay in a German-speaking region is assumed to 
enhance the level of acculturation (33). This means 
that attitudes, values, customs, beliefs, and (health) 
behaviours are adapted to another culture and the 
influence of the origin culture diminishes (33–35). It 
can be assumed that migrants who have acquired high 
levels of language skills are also well acculturated in 
other cultural dimensions. Therefore, cultural diffe-
rences within the German-speaking group of patients 
are thought to be small and of minor importance for 
health status and healthcare utilization, independent 
of migration status. 
It has been suggested that disparities in pain among 
racial and ethnic minorities may be influenced not only 
by the patient, but also by the healthcare provider and 
the healthcare system (2). In Switzerland, healthcare 
insurance is mandatory and all patients have equal 
access to the healthcare system. Nevertheless, lower 
levels of acculturation and no German language 
knowledge influenced the accessibility and use of the 
healthcare system (36). 
A comparable study examined Italian migrant wor-
kers (n = 36) and Swiss GSP (n = 49) with chronic low 
back pain (37). Both groups underwent an identical 
3-month outpatient treatment programme in different 
languages. The levels of state and change in physical 
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functioning were similar to those of our study. The Ita-
lian group showed no improvements in pain, disability, 
mental state, flexibility and strength after 3 months of 
treatment, while the GSP reported highly significant 
improvements in all measurements. 
Consistent findings revealed 2 cross-sectional 
studies: Italian patients with chronic low back pain 
reported the highest levels of emotional impairment, 
second-highest levels of social impairment, and third-
highest levels of physical impairment compared with 
different culture groups (38). Migrants from different 
countries, who lived in Switzerland for longer had 
worse health than indigenous Swiss people of the 
same age (36).
In our data, important improvements in various 
health dimensions were observed at discharge after 
intensive inpatient treatment of GSP and ISP. Im-
provements in ISP were lower and in some health 
dimensions even negative (worsening). Most of the 
short-term improvements were maintained up to mid-
term (6 or 12 months) in GSP. In contrast, ISP lost 
almost all of these improvements. This loss might be 
caused by some of the complex interactions mentioned 
above. Chronic pain can be initiated and increased 
by psychological distress caused by perceived discri-
mination (39). One possible interpretation is that the 
special needs of patients with a migration background 
may partially be met within an inpatient IPMP held in 
their native tongue, but are not generally met at home 
after discharge. At the end of the programme all pa-
tients receive individually tailored recommendations 
for subsequent outpatient management irrespective of 
the language.
The differences in outcome between GSP and ISP 
in this study cannot be explained by differences in 
the language-specific programmes, since all therapies 
and therapist were the same for both groups. Diffe-
rences in effects cannot be attributed to therapeutic 
characteristics or comprehensibility. Inequalities in 
baseline characteristics, which were (Table I) or were 
not assessed in the study, are superficial. In addition, 
heterogeneities of characteristics within the fibromy-
algia syndrome and back pain may have an impact. 
Knowing these factors, higher sample sizes would be 
needed to adjust for them. 
Reducing language barriers by administering the 
treatment in Italian language seems not to be suf-
ficient, because the improvements observed in the 
Italian group were smaller than those of the German 
group. In addition to language barriers, cultural bar-
riers have been shown to have a negative impact on 
the recovery process (35): “Cultural differences may 
result in diverging and conflicting representations of 
health, illness and therapy, and this may hinder the 
healing process or even cause its failure”. Four medi-
ating factors in intercultural care have been identified 
to facilitate or hinder the care relationship and, by that, 
the rehabilitation process: (i) humanity in care, (ii) 
communication, (iii) the role of the family, and (iv) the 
hospital’s organizational culture (40). Adapting the th-
erapy content in combination with specific intercultural 
competence training of all involved medical personal 
might enhance the treatment effect in the IPMP by 
implementing a comprehensive “cultural sensitive 
care in which patients are cared for in a holistic and 
dignity-enhancing way” (40). 
For detailed insight into these complex clinical 
situations, various factors should be further investi-
gated: (i) influence of migration details (e.g. migra-
tion background, migration trajectories), (ii) level of 
acculturation (language skills among other factors), 
(iii) identification of key aspects of intercultural com-
petence and communication in different care settings 
and health professions, (iv) adaptation of methods 
and content of treatments, (v) definition of health and 
pain, particular needs and specific expectations from 
a patient’s perspective, and (vi) choice of assessments 
to measure change of main problems of these patients. 
This study has several weaknesses. There was a lack 
of detailed information about socioeconomic status and 
migration information, including land of origin, place 
of birth and reasons for migration. Socioeconomic 
status was approximated by education and occupation 
level. The high number of patients lost to follow-up is 
a potential threat to the internal and external validity 
of this study. However, sensitivity analysis showed 
rare differences in baseline characteristics between 
the subjects who completed the study and those who 
dropped out during observation time. This means, that 
selection bias due to sex, age and SF-36 baseline score 
differences was small. A further weakness is the lack of 
knowledge about the treatment during follow-up peri-
ods after discharge. Continuation of the recommended 
therapies after dismissal was not assessed. Although 
both versions of the SF-36 have been derived from 
and validated to the English original, cross-validation 
between the German and Italian version has not been 
performed. Psychometric differences between the 2 
versions may exist and contribute to the differences 
of the outcome measurement.
A strength of this study is the naturalistic, pro-
spective study design with comparison of 2 groups 
participating in the same IPMP with the same therapy 
components in different languages. ISP received the 
same therapies as the GSP in their own language. A 
further strength is the consistency of the differences 
across 2 different samples. Although the observational, 
non-randomized study design without a control group 
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did not permit a causal statement on the effectiveness 
of the treatment, quantification and comparison of 
changes in health were possible. The differences in 
changes in health between the 2 groups were adjusted 
by cofactors that were unequally distributed at baseline 
and which possibly confounded the outcome changes.
In conclusion, ISP reported lower improvements 
in state of health after an IPMP than GSP. In the sub-
sequent follow-ups, these differences were further 
accentuated. The reasons for these differences remain 
unclear, but may have consequences for the future 
management of ISP in IPMPs. Patients with a migra-
tion background may have special needs in therapeutic 
management and addressing them might enhance the 
positive outcome in the short- and mid-term. 
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